115 related articles for article (PubMed ID: 25044301)
1. Association between ligands and receptors related to the progression of early breast cancer in tumor epithelial and stromal cells.
Labovsky V; Martinez LM; Davies KM; García-Rivello H; Calcagno Mde L; Matas A; Fernández Vallone VB; Wernicke A; Choi H; Chasseing NA
Clin Breast Cancer; 2015 Feb; 15(1):e13-21. PubMed ID: 25044301
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of TRAIL-R3 and CCR-2 expression in tumor epithelial cells of patients with early breast cancer.
Labovsky V; Martinez LM; Davies KM; de Luján Calcagno M; García-Rivello H; Wernicke A; Feldman L; Matas A; Giorello MB; Borzone FR; Choi H; Howard SC; Chasseing NA
BMC Cancer; 2017 Apr; 17(1):280. PubMed ID: 28420351
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6 receptor in spindle-shaped stromal cells, a prognostic determinant of early breast cancer.
Labovsky V; Martinez LM; Calcagno ML; Davies KM; García-Rivello H; Wernicke A; Feldman L; Giorello MB; Matas A; Borzone FR; Howard SC; Chasseing NA
Tumour Biol; 2016 Oct; 37(10):13377-13384. PubMed ID: 27460086
[TBL] [Abstract][Full Text] [Related]
4. Expression of osteoprotegerin (OPG), TNF related apoptosis inducing ligand (TRAIL), and receptor activator of nuclear factor kappaB ligand (RANKL) in human breast tumours.
Van Poznak C; Cross SS; Saggese M; Hudis C; Panageas KS; Norton L; Coleman RE; Holen I
J Clin Pathol; 2006 Jan; 59(1):56-63. PubMed ID: 16394281
[TBL] [Abstract][Full Text] [Related]
5. Expression of receptor activator of nuclear factor kappabeta ligand (RANKL) and tumour necrosis factor related, apoptosis inducing ligand (TRAIL) in breast cancer, and their relations with osteoprotegerin, oestrogen receptor, and clinicopathological variables.
Cross SS; Harrison RF; Balasubramanian SP; Lippitt JM; Evans CA; Reed MW; Holen I
J Clin Pathol; 2006 Jul; 59(7):716-20. PubMed ID: 16489180
[TBL] [Abstract][Full Text] [Related]
6. STAT-6 mediates TRAIL induced RANK ligand expression in stromal/preosteoblast cells.
Sundaram K; Sambandam Y; Balasubramanian S; Pillai B; Voelkel-Johnson C; Ries WL; Reddy SV
Bone; 2015 Feb; 71():137-44. PubMed ID: 25445452
[TBL] [Abstract][Full Text] [Related]
7. Expression of osteoprotegerin, receptor activator of nuclear factor kappa-B ligand, tumor necrosis factor-related apoptosis-inducing ligand, stromal cell-derived factor-1 and their receptors in epithelial metastatic breast cancer cell lines.
Labovsky V; Vallone VB; Martinez LM; Otaegui J; Chasseing NA
Cancer Cell Int; 2012 Jun; 12(1):29. PubMed ID: 22709548
[TBL] [Abstract][Full Text] [Related]
8. Influence of stromal-epithelial interactions on breast cancer in vitro and in vivo.
Potter SM; Dwyer RM; Hartmann MC; Khan S; Boyle MP; Curran CE; Kerin MJ
Breast Cancer Res Treat; 2012 Jan; 131(2):401-11. PubMed ID: 21344235
[TBL] [Abstract][Full Text] [Related]
9. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ
J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644
[TBL] [Abstract][Full Text] [Related]
10. Interaction of ligand-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasis.
Mochizuki H; Matsubara A; Teishima J; Mutaguchi K; Yasumoto H; Dahiya R; Usui T; Kamiya K
Biochem Biophys Res Commun; 2004 Jul; 320(3):656-63. PubMed ID: 15240098
[TBL] [Abstract][Full Text] [Related]
11. Human bone marrow stromal cells protect prostate cancer cells from TRAIL-induced apoptosis.
Nyambo R; Cross N; Lippitt J; Holen I; Bryden G; Hamdy FC; Eaton CL
J Bone Miner Res; 2004 Oct; 19(10):1712-21. PubMed ID: 15355567
[TBL] [Abstract][Full Text] [Related]
12. RANKL promotes the growth of decidual stromal cells in an autocrine manner via CCL2/CCR2 interaction in human early pregnancy.
Meng YH; Li H; Chen X; Liu LB; Shao J; Chang KK; Du MR; Jin LP; Li MQ; Li DJ
Placenta; 2013 Aug; 34(8):663-71. PubMed ID: 23697850
[TBL] [Abstract][Full Text] [Related]
13. Infantile haemangioma expresses tumour necrosis factor-related apoptosis-inducing ligand (TRAIL), TRAIL receptors, osteoprotegerin and receptor activator for nuclear factor кB ligand (RANKL).
Vishvanath A; Itinteang T; Tan ST; Day DJ
Histopathology; 2011 Sep; 59(3):397-406. PubMed ID: 22034880
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stromal cells for bone sarcoma treatment: Roadmap to clinical practice.
Stamatopoulos A; Stamatopoulos T; Gamie Z; Kenanidis E; Ribeiro RDC; Rankin KS; Gerrand C; Dalgarno K; Tsiridis E
J Bone Oncol; 2019 Jun; 16():100231. PubMed ID: 30956944
[TBL] [Abstract][Full Text] [Related]
15. Soluble TRAIL could enhance bone destruction acting on Rank-ligand in estrogen-independent human breast cancer cell line MDA-MB-231.
Nicolin V; Narducci P
Acta Histochem; 2010 Mar; 112(2):189-92. PubMed ID: 19058836
[TBL] [Abstract][Full Text] [Related]
16. Direct crosstalk between cancer and osteoblast lineage cells fuels metastatic growth in bone via auto-amplification of IL-6 and RANKL signaling pathways.
Zheng Y; Chow SO; Boernert K; Basel D; Mikuscheva A; Kim S; Fong-Yee C; Trivedi T; Buttgereit F; Sutherland RL; Dunstan CR; Zhou H; Seibel MJ
J Bone Miner Res; 2014 Sep; 29(9):1938-49. PubMed ID: 24676805
[TBL] [Abstract][Full Text] [Related]
17. Expression of receptor activator of nuclear factor kappa-B as a poor prognostic marker in breast cancer.
Park HS; Lee A; Chae BJ; Bae JS; Song BJ; Jung SS
J Surg Oncol; 2014 Dec; 110(7):807-12. PubMed ID: 25111682
[TBL] [Abstract][Full Text] [Related]
18. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.
Chen X; Kandasamy K; Srivastava RK
Cancer Res; 2003 Mar; 63(5):1059-66. PubMed ID: 12615723
[TBL] [Abstract][Full Text] [Related]
19. Modulation of tumor necrosis factor related apoptosis-inducing ligand (TRAIL) receptors in a human osteoclast model in vitro.
McManus S; Chamoux E; Bisson M; Roux S
Apoptosis; 2012 Feb; 17(2):121-31. PubMed ID: 21972115
[TBL] [Abstract][Full Text] [Related]
20. Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing.
Kon T; Cho TJ; Aizawa T; Yamazaki M; Nooh N; Graves D; Gerstenfeld LC; Einhorn TA
J Bone Miner Res; 2001 Jun; 16(6):1004-14. PubMed ID: 11393777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
